INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 13 Apr · 18:21 IST

Significant increase in volume has been observed in Ind-Swift Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ind-Swift Laboratories Limited has submitted their response.

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.0%1-day move
₹138.53
prior close
₹141.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+1.6+0.4+2.0+5.0-4.6+1.4+4.0+2.9-1.7+1.1-1.8+17.2+63.9
Up moveDown movePending
AI summary

NSE wrote to Ind-Swift Laboratories asking why its share volume spiked. The company responded that it was unaware of any specific reason except the disclosure made on 7th April 2026 about an arbitration award. The arbitration involved PI Industries Limited, and the tribunal rejected BOTH the claimant's claims AND Ind-Swift's counterclaims. The proceedings are now concluded with NIL financial impact on the company. The company states it has complied with all SEBI listing regulations and that the volume increase appears to be market-driven.

Likely market impact

The arbitration outcome is neutral for shareholders - no financial gain or loss. The volume surge reflects market speculation, but the actual award provides no immediate catalyst for the stock.